CPD and Education library

Study and gain CPD points through OT’s online CPD exams, and access archived CPD and CET articles, Practice team resources and Skills guides in our Education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Virus-based treatment for retinoblastoma shows promising results

A new potential therapy for retinoblastoma has had positive effects in mouse models and a pilot clinical trial involving two patients

A small child's eye

A potential treatment for retinoblastoma has shown promising results in mouse models and a pilot clinical trial.

The research, which was described in Science Translational Medicine, involved harnessing a virus that infects and kills cells with the dysfunctional genetic pathway that leads to retinoblastoma.

The treatment, named VCN-01, was found to be safe in rabbits. Mice with retinoblastoma who were injected with the therapy experienced curtailed tumour growth compared to mice treated with chemotherapy.

The new treatment also prevented metastasis and extended the time to enucleation.

In two paediatric patients with retinoblastoma, VCN-01 replicated within tumour cells without causing systemic inflammation.

The authors highlighted that these results suggest the virus-based treatment warrants further investigation.